Senti Biosciences Holdings, Inc. (NASDAQ:SNTI) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Edward Mathers Other companies: NeueHealth Inc (Director · Since at least Oct 2, 2025); MBX Biosciences, Inc. (Director · Since at least Sep 12, 2024); OnKure Therapeutics, Inc. (Director · Since at least Apr 8, 2021); Trevi Therapeutics, Inc. (Director · Since at least May 7, 2019); Rhythm Pharmaceuticals, Inc. (Director · Since at least Oct 4, 2017); Inozyme Pharma Inc (Director · Jul 23, 2020 – Jun 18, 2024 · Past); Akouos Inc (Director · Jun 25, 2020 – Dec 1, 2022 · Past); Mirum Pharmaceuticals, Inc. (Director · Jul 17, 2019 – Jun 2, 2022 · Past); Ra Pharmaceuticals Inc (Director · Jun 28, 2018 – Apr 2, 2020 · Past); Synlogic Inc (Director · Dec 29, 2017 – Jun 22, 2023 · Past) | Director · Since at least Jun 8, 2022 |
| Jay Flatley Other companies: Rivian Automotive, Inc. (Member · Since at least Nov 9, 2021); Denali Therapeutics Inc. (Director · Since at least Dec 7, 2017); Zymergen Inc (Chairman and Acting CEO, Director · Apr 21, 2021 – Oct 19, 2022 · Past); Juno Therapeutics Inc (Director · May 22, 2017 – Mar 5, 2018 · Past); Coherent Corp. (Director · Sep 20, 2011 – Jul 1, 2022 · Past); Illumina, Inc. (Director · Jan 10, 2006 – May 18, 2021 · Past) | Director · May 25, 2021 – May 25, 2021 · Past |
| Mostafa Ronaghi Other companies: Summit Therapeutics Inc. (Non-Executive Director · Since at least Apr 11, 2024); Seer, Inc. (Director · Feb 13, 2021 – Jun 14, 2023 · Past); Illumina, Inc. (SVP, Entrepreneurial Devlopmt · Apr 23, 2013 – Dec 10, 2020 · Past) | Chief Executive Officer, Director · May 25, 2021 – May 25, 2021 · Past |
| Omid Farokhzad Other companies: Seer, Inc. (Chair and Chief Executive Officer · Since at least Dec 3, 2020); Cartesian Therapeutics, Inc. (Director · Jun 21, 2016 – Jun 14, 2019 · Past); BIND Therapeutics Inc (Director · Sep 19, 2013 – Sep 19, 2013 · Past) | Director · May 25, 2021 – Jul 10, 2024 · Past |
| James J Collins Other companies: Orion Biotech Opportunities Corp (Director · May 12, 2021 – May 17, 2023 · Past); Fulcrum Therapeutics, Inc. (Director · Jul 17, 2019 – Jun 17, 2024 · Past) | Director · Since at least Jun 8, 2022 |
| Kanya Rajangam Other companies: Turnstone Biologics Corp. (Director · Jul 20, 2023 – Jun 3, 2024 · Past); Nkarta, Inc. (Chief Medical Officer · Jul 9, 2020 – Jan 14, 2022 · Past) | Pres. & Chief Med. & Dev. Off. · Since at least Jul 5, 2022 |
| Brenda Cooperstone Other companies: Lexeo Therapeutics, Inc. (Board Member · Since at least Nov 2, 2023) | Director · Since at least Jun 8, 2022 |
| Curt A Herberts III Other companies: Sangamo Therapeutics, Inc. (Sr.VP & Chief Business Officer · Nov 30, 2016 – Apr 13, 2018 · Past) | Chief Operating Officer · Jun 8, 2022 – Jun 8, 2022 · Past |
| Deborah Knobelman Other companies: Kronos Bio Inc (President & Interim CEO · Since at least Jun 3, 2024) | Chief Financial Officer · Jun 8, 2022 – Feb 1, 2024 · Past |
| Donald F Tang Other companies: Vicarious Surgical, Inc. (Director · Since at least Jul 14, 2020) | Director · Since at least Dec 9, 2024 |
| Fran Schulz Other companies: Edap Tms SA (Director · Since at least Jan 1, 2026) | Director · Since at least Dec 9, 2024 |
| John Harry Cross III Other companies: Chanticleer Holdings Inc (Chief Financial Officer · Apr 1, 2020 – Dec 11, 2023 · Past) | Chief Financial Officer · Mar 3, 2025 – Mar 7, 2025 · Past |
| Rowan E Chapman Other companies: Natera, Inc. (Director · Since at least Aug 15, 2019) | Chief Business Officer · May 25, 2021 – May 25, 2021 · Past |
| Yvonne Li Other companies: OncoMed Pharmaceuticals Inc (See Remarks · Mar 16, 2018 – Apr 23, 2019 · Past) | Interim CFO · May 4, 2024 – May 4, 2024 · Past |
| Bryan Baum | Director · Since at least Jul 18, 2025 |
| Feng Hsiung | Director · Since at least Mar 7, 2025 |
| Fran Schulz | Director · Since at least Dec 2, 2024 |
| Jay Cross | Chief Financial Officer · Since at least Feb 25, 2025 |
| Jenene Thomas | Chief Executive Officer · Since at least Jan 14, 2026 |
| Mark Afrasiabi | Chief Financial Officer · May 25, 2021 – May 25, 2021 · Past |
| Philip J Lee | Chief Technology Officer · Jun 8, 2022 – Feb 1, 2023 · Past |
| Susan D Berland | Director · Jun 8, 2022 – Jun 16, 2023 · Past |
| Timothy K Lu | CEO, Director · Since at least Jun 8, 2022 |